Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment for Psoriasis
NCT06396013Phase 1Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jun 2024
- Primary completion
- Jun 2026
01
Overview
Phase 1, randomised, double-blind trial of qinteng huoxue runji in plaque psoriasis, sponsored by Beijing Hospital of Traditional Chinese Medicine. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
qinteng huoxue runji
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06396013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06396013.